Smart Medicine, 2023 · DOI: 10.1002/SMMD.20220038 · Published: January 1, 2023
The study introduces a new method for delivering drugs to help repair spinal cord injuries. It uses tiny spheres made of a special gel (GelMA) that can hold and slowly release a growth factor (bFGF). These spheres are designed to be injected into the injured area of the spinal cord to promote nerve regeneration. The small size of the hydrogel microspheres allows them to be injected and inhaled through small needles and catheters, facilitating minimally invasive delivery of cells and biologicals. The microspheres' porous structure allows them to control the release of biological agents for long‐term therapeutic effects. The level of the porosity is related to the size and packing density of hydrogel microspheres, which can regulate the proliferation and migration of supporting cells and effectively control the release of biological agents for long‐term therapeutic effects.
The GelMA microsphere system shows promise as a drug delivery platform for neurotrophic factors to treat spinal cord injuries.
The successful in vivo results suggest potential for clinical translation of this approach for SCI treatment.
This study supports the use of drug-loaded microspheres as a promising platform for regenerative medicine in CNS injuries.